Safety and efficacy after switch to a saquinavir-containing antiretroviral regimen in protease inhibitor pretreated HIV-positive patients

被引：0
|
作者：
C Stephan
H Jaeger
A Carganico
G Knecht
T Lutz
C Mayr
FA Mosthaf
S Koeppe
M Mueller
E Wolf
A Tappe
E Wellmann
H Knechten
机构：
[1] Klinikum der Johann-Wolfgang-Goethe-Universität,MVZ Karlsplatz
[2] HIV Research and Clinical Care Centre,undefined
[3] Praxis Dres. S. Dupke/A. Carganico/A. Baumgarten,undefined
[4] Infektiologikum Frankfurt,undefined
[5] MVZ-Aerzteforum Seestrasse,undefined
[6] Praxis Dres. F. A. Mosthaf/M. Procaccianti/K. Zutavern-Bechtold,undefined
[7] Praxis Dres. S. Koeppe/P. Kreckel,undefined
[8] Praxis Dres. B. Frietsch/A. Ulmer/M. Mueller,undefined
[9] MUC Research,undefined
[10] Roche Pharma AG,undefined
[11] Praxenzentrum Blondelstrasse (PZB),undefined
来源：
European Journal of Medical Research | / 15卷
关键词：
HIV; protease inhibitor; saquinavir; cholesterol; triglycerides;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] SAFETY AND EFFICACY AFTER SWITCH TO A SAQUINAVIR-CONTAINING ANTIRETROVIRAL REGIMEN IN PROTEASE INHIBITOR PRETREATED HIV-POSITIVE PATIENTS
    Stephan, C.
    Jaeger, H.
    Carganico, A.
    Knecht, G.
    Lutz, T.
    Mayr, C.
    Mosthaf, F. A.
    Koeppe, S.
    Mueller, M.
    Wolf, E.
    Tappe, A.
    Wellmann, E.
    Knechten, H.
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2010, 15 (09) : 369 - 376
  • [2] Safety and Efficacy of a Saquinavir-Containing Antiretroviral Regimen in Previously ART-Naive or Pretreated but Protease Inhibitor-Naive HIV-Positive Patients
    Knechten, H.
    Stephan, C.
    Mosthaf, F. A.
    Jaeger, H.
    Lutz, T.
    Cargnico, A.
    Stoehr, A.
    Koeppe, S.
    Mayr, C.
    Schewe, K.
    Wolf, E.
    Wellmann, E.
    Tappe, A.
    INFECTION, 2010, 38 (02) : 108 - 116
  • [3] Safety and Efficacy of a Saquinavir-Containing Antiretroviral Regimen in Previously ART-Naïve or Pretreated but Protease Inhibitor-Naïve HIV-Positive Patients
    H. Knechten
    C. Stephan
    F. A. Mosthaf
    H. Jaeger
    T. Lutz
    A. Cargnico
    A. Stoehr
    S. Koeppe
    C. Mayr
    K. Schewe
    E. Wolf
    E. Wellmann
    A. Tappe
    Infection, 2010, 38 : 108 - 116
  • [4] Pilot study of saquinavir and lopinavir/ritonavir twice daily in protease inhibitor-naive HIV-positive patients
    Hellinger, J
    Cohen, C
    Morris, A
    Sheble-Hall, S
    Gordon, D
    Foy, C
    Jackson-Pope, L
    Shevitz, A
    van Schaic, E
    HIV CLINICAL TRIALS, 2005, 6 (02): : 107 - 117
  • [5] Exploring the possibility of switching to a single-tablet regimen for HIV-positive patients on a protease inhibitor (PI)-based regimen
    Rosenvinge, M.
    Bottoni, G.
    Buckberry, K.
    Collins, N.
    Russell, J.
    HIV MEDICINE, 2016, 17 : 25 - 25
  • [6] EFFICACY AND SAFETY OF AN ANTIRETROVIRAL REGIMEN CONTAINING RALTEGRAVIR IN HIV-1 TREATMENT EXPERIENCED PATIENTS
    Di Biagio, A.
    Lo Caputo, S.
    Malfatto, E.
    Rosso, R.
    Vichi, F.
    Pierotti, P.
    Bernardini, C.
    Di Pietro, M.
    Viscoli, C.
    Mazzotta, F.
    INFECTION, 2009, 37 : 67 - 67
  • [7] Maintenance of breast size reduction after mastoplasty and switch to a protease inhibitor-sparing regimen in an HIV-positive woman with highly active antiretroviral therapy-associated massive breast enlargement
    Gervasoni, C
    Ridolfo, AL
    Rovati, L
    Vaccarezza, M
    Cassana, L
    Galli, M
    AIDS PATIENT CARE AND STDS, 2002, 16 (07) : 307 - 311
  • [8] Raltegravir Plus Nevirapine as Maintenance Antiretroviral Therapy in HIV-Positive Patients: Safety, Efficacy and Pharmacokinetics
    Calcagno, Andrea
    Montrucchio, Chiara
    Capetti, Amedeo
    Guaraldi, G.
    Cenderello, G.
    Calza, Leonardo
    Lanzafame, M.
    Marinaro, Letizia
    Tettoni, M. C.
    Trentini, Laura
    D'Avolio, Aantonio
    Di Perri, Giovanni
    Bonora, Stefano
    CURRENT HIV RESEARCH, 2016, 14 (01) : 54 - 60
  • [9] Antiretroviral treatment regimen adjustments in HIV-positive patients at a clinic in Gauteng Province
    Bronkhorst, Elmien
    Nxumalo, Ntando
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 657 - 657
  • [10] High-dose saquinavir plus ritonavir:: Long-term efficacy in HIV-positive protease inhibitor-experienced patients and predictors of virologic response
    Paredes, R
    Puig, T
    Arnó, A
    Negredo, E
    Balagué, M
    Bonjoch, A
    Jou, A
    Tuldrà, A
    Tural, C
    Sirera, G
    Veny, A
    Romeu, J
    Ruiz, L
    Clotet, B
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1999, 22 (02): : 132 - 138
12345